about
Probing the catalytic potential of the hamster arylamine N-acetyltransferase 2 catalytic triad by site-directed mutagenesis of the proximal conserved residue, Tyr190.Combining perfluorocarbon and superparamagnetic iron-oxide cell labeling for improved and expanded applications of cellular MRI.A new nano-sized iron oxide particle with high sensitivity for cellular magnetic resonance imagingA new approach to reduce toxicities and to improve bioavailabilities of platinum-containing anti-cancer nanodrugs.Tracking T-cells in vivo with a new nano-sized MRI contrast agentDecreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid.A New Method for Preparing Mesenchymal Stem Cells and Labeling with Ferumoxytol for Cell Tracking by MRIMagnetic resonance imaging investigation of macrophages in acute cardiac allograft rejection after heart transplantation.Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.Human arylamine N-acetyltransferase 1: in vitro and intracellular inactivation by nitrosoarene metabolites of toxic and carcinogenic arylamines.Catalytic mechanism of hamster arylamine N-acetyltransferase 2.A New Approach to Deliver Anti-cancer Nanodrugs with Reduced Off-target Toxicities and Improved Efficiency by Temporarily Blunting the Reticuloendothelial System with Intralipid.Mesenchymal Stem Cell Preparation and Transfection-free Ferumoxytol Labeling for MRI Cell Tracking.Mapping immune cell infiltration using restricted diffusion MRI.A Fatty Acid-Inspired Tetherable Initiator for Surface-Initiated Atom Transfer Radical PolymerizationIntralipid ® attenuates acute cardiac allograft rejection in relation to promoting CD4 + CD25 + Foxp3 + regulatory T-cells and inhibiting toll-like receptor 4 expressionA New Approach to Decrease the RES Uptake of Nanodrugs by Pre-administration with Intralipid® Resulting in a Reduction of Toxic Side EffectsArylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2
P50
Q33587691-5B0CE04E-70A5-47EE-AF1D-A662C115BD26Q33969361-4D84CD7F-BCBD-4953-8876-AD5AB5FA8EE0Q34927786-11477E4E-0281-4FE1-B015-8E438F2A8EA9Q35679127-BA3C4263-6B22-4855-9009-C7FB72FDFA90Q36060729-3A7C4207-A5BE-4F92-8368-9C59C0A0F156Q36807762-25BD82A0-102E-4452-A08B-38962C6CF724Q36911124-F96B7795-9E87-4B87-B19C-021400CB9C18Q37457454-3A976791-D1A3-444D-86AE-D46D3D36C356Q43258342-4D998B91-F124-4922-8E81-ED2385421B5FQ46401470-A9D19E3F-7FF2-477B-BEC9-5819A86DC1C8Q46651171-62D5C3BF-7F39-4E30-8187-3A56F5D46187Q47162722-086FF9CE-2082-4D68-9AFF-9E7AAE70D692Q48518162-CB1EC558-2368-4B2A-97B3-40FD4974EB68Q48630021-0CAF247B-8B79-4D85-9A29-1F37B5B64D3AQ59867475-4286F871-C1BF-4BE6-8A70-EB17C6164AA5Q64004755-E0EABD9E-09C8-49F6-8E5A-FE2401D7C27DQ64004756-7E310628-3967-4DE1-84D3-A873D89F0227Q80728873-6D16BD90-33CD-411D-8792-6CB0E8DE61F3
P50
description
researcher ORCID: 0000-0003-2493-3086
@en
name
Li Liu
@ast
Li Liu
@en
Li Liu
@nl
Li Liu
@sl
type
label
Li Liu
@ast
Li Liu
@en
Li Liu
@nl
Li Liu
@sl
prefLabel
Li Liu
@ast
Li Liu
@en
Li Liu
@nl
Li Liu
@sl
P106
P31
P496
0000-0003-2493-3086